Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Reply: BAL lymphocyte percentage is as good as the company it keeps
Nicola Adderley, Christopher J. Humphreys, Hayley Barnes, Zahra A. Premji, Kerri A. Johannson
Eur Respir J, 57 (2) 2100092; 10.1183/13993003.00092-2021
Interstitial lung diseases
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nicola Adderley, Christopher J. Humphreys, Hayley Barnes, Zahra A. Premji, Kerri A. Johannson. Reply: BAL lymphocyte percentage is as good as the company it keeps. Eur Respir J, 57 (2) 2100092; 10.1183/13993003.00092-2021
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
HISTOLOGICAL FINDINGS IN TRANSBRONCHIAL CRYOBIOPSIES OBTAINED FROM PATIENTS AFTER COVID-19
The impact of anti-IgE treatment on the airway microbiome in asthma.
Does “UIPAF” really exist?
Related content which might interest you:
Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no!
Source: Eur Respir J, 51 (5) 1800730; 10.1183/13993003.00730-2018
Pulmonary dendritic cells: playing ball in the BAL?
Source: Eur Respir J 2007; 30: 823-824
Normal values for bronchoalveolar lavage (BAL) differential cell count and lymphocyte subpopulations
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Late Breaking Abstract - Revisiting interpretation of blood eosinophil counts (BECs): data from Brazil
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Alveolar lymphocytes (AL) in healthy individuals are mostly effector T cells. The flow cytometry (FC) lesson for interstitial lung diseases (ILD) evaluation
Source: International Congress 2016 – ILD pathogenesis
LSC 2010 Abstract: Increase in serum and sputum perforin expression in persistent asthma: Preliminary results
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Which CD8+ T-cells in asthma? Attacking or defending?
Source: Eur Respir J 2016; 48: 287-290
Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
BAL cell counts in the diagnosis of lung diseases: is there a gain in information?
Source: Eur Respir J 2002; 20: Suppl. 38, 173s
Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases
Source: Eur Respir J 2004; 24: 1000-1006
Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD.
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
T lymphocyte subsets in bronchoalveolar lavage: A flow cytometric and its importance in the differntial diagnosis of sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 265s
The meaning of a high monocyte to lymphocyte ratio in tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Interferon gamma (IFNgamma) decreases apoptosis rate of antigen primed T helper lymphocytes from bronchoalveolar lavage (BAL)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Does the peripheral blood neutrophil lymphocyte ratio increase as the stage of sarcoidosis progresses?
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
COPD treatment choices based on blood eosinophils: are we there yet?
Source: Breathe, 15 (4) 318; 10.1183/20734735.0254-2019
cells are expanded among bronchoalveolar lymphocytes in healthy tuberculosis contacts with positive interferon-γ release assay responses
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD?
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Elevated blood eosinophils in bronchiectasis: A distinct phenotype?
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Late Breaking Abstract - Characterization of the immunological profile of COVID-19 patients and correlation of CD4+ and CD8+ T lymphocytes with disease severity during hospitalization.
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19